Solventum Veraflo Therapy
Manage bioburden with Veraflo Therapy
40% of all wounds are infected or critically colonized.1
Veraflo Therapy, designed to support the hydromechanical removal of non-viable tissue while delivering the proven advantages of negative pressure wound therapy (NPWT), can be part of the treatment plan for infected wounds. Veraflo Therapy allows the instillation of topical wound solutions that can help manage the bacterial population through repeated cleansing cycles, thus, interrupting the bioburden lifecycle. Reduction of bacterial bioburden with the use of Veraflo Therapy has been reported to positively impact the wound healing process.2,3
Three successive applications - dressing change every 3 days Veraflo Therapy applied with saline instillation and Veraflo Cleanse Choice™ Dressing.5
Images displayed: A) Before Veraflo Therapy, Day 0 B) After Veraflo Therapy, Day 9
How Veraflo Therapy works
Veraflo Therapy vs. standard of care
Veraflo Therapy has demonstrated positive clinical outcomes when compared to standard care including traditional NPWT.8 In a systematic review of comparative studies and meta-analysis,8 the performance of Veraflo Therapy was evaluated in 13 studies involving 720 patients, with various wound types. Veraflo Therapy was shown to deliver significant advantages over standard of care, including improved wound management.
- >30% fewer surgical debridements8,9 (1.77 debridement's vs 2.69, p=0.008)
- Wounds were 2.39 times more likely to close8 (p=0.01)
- >50% reduced length of therapy8,9 (9.88 days vs 21.8 days, p=0.02)
- Reduced bacterial count from baseline8 (Odds were 4.4 times greater p=0.003)
- Ready for closure almost twice as fast8,9 (7.88 days vs 14.36 days, p=0.003)
- Study limitations, including high patient and wound population heterogeneity across studies, require cautious interpretation of the results.
Veraflo Therapy products
Explore a range of accessories designed for use with Veraflo Therapy to create an environment that promotes wound healing and improves patient outcomes.
Take the next steps with your wound care needs
Education & resources
Featured documents
Veraflo Therapy: How-to videos
Additional support
References:
- September 2014 Survey, N = 240, Surgeons, Podiatrists, WOCNs and PT.
- Gabriel A. Integrated negative pressure wound therapy system with volumetric automated fluid instillation in wounds at risk for compromised healing. Int Wound J. 2012; 9 Suppl 1:25-31.
- Wolvos TA, Negative pressure wound therapy with instillation: the current state of the art, Surgical Technology International. 2014; 24:53-62.
- Zhan C, Miller MR. Excess Length of Stay, Charges, and Mortality Attributable to Medical Injuries During Hospitalization. JAMA. 2003; 290(14): 1868-74.
- Teot L, Boissiere F, Fluieraru S. Novel foam dressing using negative pressure wound therapy with instillation to remove thick exudate. Int Wound J. 2017;14(5):842-848.
- Brinkert D, Mazen A, Naud M, Maire N, Trial C, Teot L. Negative pressure wound therapy with saline instillation: 131 patient case series. Int Wound J. 2013;10 Suppl 1:56-60.
- Gupta S, Gabriel A, Lantis J, Teot L. Clinical recommendations and practical guide for negative pressure wound therapy with instillation. Int Wound J. 2016;13(2):159-174.
- Gabriel A, Camardo M, O’Rorke E, Gold R, Kim PJ. Effects of Negative-Pressure Wound Therapy With Instillation versus Standard of Care in Multiple Wound Types: Systematic Literature Review and Meta-Analysis. Plast Reconstr Surg. 2021 ;147(1S-1):68S-76S.
- Kim PJ, Lookess S, Bongards C, Griffin LP, Gabriel A. Economic model to estimate cost of negative pressure wound therapy with instillation vs control therapies for hospitalised patients in the United States, Germany, and United Kingdom. Int Wound J. 2021;1–7.
- Ref 3M™ V.A.C.® Ulta Negative Pressure Wound Therapy System Safety Information and 3M™ V.A.C. Veraflo Cleanse Choice™ Dressing System Application Instructions.